Discontinued — last reported Q3 '23
Higher values indicate significant investment in proprietary technology or market access, though they require monitoring for potential impairment.
This represents the net value of identifiable intangible assets with a limited useful life, such as patents, licenses, o...
Common in technology, pharmaceutical, and defense firms that acquire or develop proprietary intellectual property.
non_current_assets_finite_lived_intangible_assets_net| Q1 '26 | |
|---|---|
| Value | $15.36M |